WallStSmart

MercadoLibre Inc. (MELI)vsNatural Health Trend (NHTC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MercadoLibre Inc. generates 72539% more annual revenue ($28.89B vs $39.78M). MELI leads profitability with a 6.9% profit margin vs -2.2%. MELI appears more attractively valued with a PEG of 0.76. MELI earns a higher WallStSmart Score of 62/100 (C+).

MELI

Buy

62

out of 100

Grade: C+

Growth: 7.3Profit: 6.5Value: 7.3Quality: 5.3
Piotroski: 2/9Altman Z: 2.04

NHTC

Avoid

28

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 4.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MELISignificantly Overvalued (-654.6%)

Margin of Safety

-654.6%

Fair Value

$267.44

Current Price

$1639.47

$1372.03 premium

UndervaluedFair: $267.44Overvalued

Intrinsic value data unavailable for NHTC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MELI5 strengths · Avg: 9.0/10
Return on EquityProfitability
36.0%10/10

Every $100 of equity generates 36 in profit

Revenue GrowthGrowth
44.6%10/10

Revenue surging 44.6% year-over-year

Market CapQuality
$81.72B9/10

Large-cap with strong market position

PEG RatioValuation
0.768/10

Growing faster than its price suggests

Free Cash FlowQuality
$4.78B8/10

Generating 4.8B in free cash flow

NHTC1 strengths · Avg: 10.0/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Areas to Watch

MELI4 concerns · Avg: 3.0/10
Price/BookValuation
12.3x4/10

Trading at 12.3x book value

Profit MarginProfitability
6.9%3/10

6.9% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

P/E RatioValuation
41.0x2/10

Premium valuation, high expectations priced in

NHTC4 concerns · Avg: 2.3/10
Market CapQuality
$32.70M3/10

Smaller company, higher risk/reward

PEG RatioValuation
13.452/10

Expensive relative to growth rate

Return on EquityProfitability
-3.1%2/10

ROE of -3.1% — below average capital efficiency

Revenue GrowthGrowth
-10.1%2/10

Revenue declined 10.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : MELI

The strongest argument for MELI centers on Return on Equity, Revenue Growth, Market Cap. Revenue growth of 44.6% demonstrates continued momentum. PEG of 0.76 suggests the stock is reasonably priced for its growth.

Bull Case : NHTC

The strongest argument for NHTC centers on Price/Book.

Bear Case : MELI

The primary concerns for MELI are Price/Book, Profit Margin, Piotroski F-Score. A P/E of 41.0x leaves little room for execution misses.

Bear Case : NHTC

The primary concerns for NHTC are Market Cap, PEG Ratio, Return on Equity.

Key Dynamics to Monitor

MELI profiles as a hypergrowth stock while NHTC is a turnaround play — different risk/reward profiles.

MELI carries more volatility with a beta of 1.53 — expect wider price swings.

MELI is growing revenue faster at 44.6% — sustainability is the question.

MELI generates stronger free cash flow (4.8B), providing more financial flexibility.

Bottom Line

MELI scores higher overall (62/100 vs 28/100) and 44.6% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MercadoLibre Inc.

CONSUMER CYCLICAL · INTERNET RETAIL · USA

MercadoLibre, Inc. operates online trading platforms in Latin America. The company is headquartered in Buenos Aires, Argentina.

Natural Health Trend

CONSUMER CYCLICAL · INTERNET RETAIL · USA

Natural Health Trends Corp. The company is headquartered in Tsim Sha Tsui, Hong Kong.

Want to dig deeper into these stocks?